▶ 調査レポート

世界のコハク酸ドキシラミン市場 2028年:固体、液体

• 英文タイトル:Global Doxylamine Succinate Market Insights, Forecast to 2028

Global Doxylamine Succinate Market Insights, Forecast to 2028「世界のコハク酸ドキシラミン市場 2028年:固体、液体」(市場規模、市場予測)調査レポートです。• レポートコード:QY2207C0161
• 出版社/出版日:QYResearch / 2022年7月15日
• レポート形態:英文、PDF、91ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のコハク酸ドキシラミンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にコハク酸ドキシラミンの世界市場のxxx%を占める「固体」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「抗ヒスタミン薬」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のコハク酸ドキシラミンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのコハク酸ドキシラミン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのコハク酸ドキシラミン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

コハク酸ドキシラミンのグローバル主要メーカーには、Teva、CHATTEM、DUCHESNAY、LNK INTERNATIONAL INC、PERRIGO、Viatris (MYLAN)、Osmopharm、PAR PHARM INC、Renata Ltdなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

コハク酸ドキシラミン市場は、種類と用途によって区分されます。世界のコハク酸ドキシラミン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
固体、液体

【用途別セグメント】
抗ヒスタミン薬、抗コリン作用薬、鎮静薬、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- コハク酸ドキシラミン製品概要
- 種類別市場(固体、液体)
- 用途別市場(抗ヒスタミン薬、抗コリン作用薬、鎮静薬、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のコハク酸ドキシラミン販売量予測2017-2028
- 世界のコハク酸ドキシラミン売上予測2017-2028
- コハク酸ドキシラミンの地域別販売量
- コハク酸ドキシラミンの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別コハク酸ドキシラミン販売量
- 主要メーカー別コハク酸ドキシラミン売上
- 主要メーカー別コハク酸ドキシラミン価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(固体、液体)
- コハク酸ドキシラミンの種類別販売量
- コハク酸ドキシラミンの種類別売上
- コハク酸ドキシラミンの種類別価格
・用途別市場規模(抗ヒスタミン薬、抗コリン作用薬、鎮静薬、その他)
- コハク酸ドキシラミンの用途別販売量
- コハク酸ドキシラミンの用途別売上
- コハク酸ドキシラミンの用途別価格
・北米市場
- 北米のコハク酸ドキシラミン市場規模(種類別、用途別)
- 主要国別のコハク酸ドキシラミン市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのコハク酸ドキシラミン市場規模(種類別、用途別)
- 主要国別のコハク酸ドキシラミン市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のコハク酸ドキシラミン市場規模(種類別、用途別)
- 主要国別のコハク酸ドキシラミン市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のコハク酸ドキシラミン市場規模(種類別、用途別)
- 主要国別のコハク酸ドキシラミン市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのコハク酸ドキシラミン市場規模(種類別、用途別)
- 主要国別のコハク酸ドキシラミン市場規模(トルコ、サウジアラビア)
・企業情報
Teva、CHATTEM、DUCHESNAY、LNK INTERNATIONAL INC、PERRIGO、Viatris (MYLAN)、Osmopharm、PAR PHARM INC、Renata Ltd
・産業チェーン及び販売チャネル分析
- コハク酸ドキシラミンの産業チェーン分析
- コハク酸ドキシラミンの原材料
- コハク酸ドキシラミンの生産プロセス
- コハク酸ドキシラミンの販売及びマーケティング
- コハク酸ドキシラミンの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- コハク酸ドキシラミンの産業動向
- コハク酸ドキシラミンのマーケットドライバー
- コハク酸ドキシラミンの課題
- コハク酸ドキシラミンの阻害要因
・主な調査結果

Market Analysis and Insights: Global Doxylamine Succinate Market
Due to the COVID-19 pandemic, the global Doxylamine Succinate market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Solid accounting for % of the Doxylamine Succinate global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Antihistamine segment is altered to an % CAGR throughout this forecast period.
China Doxylamine Succinate market size is valued at US$ million in 2021, while the US and Europe Doxylamine Succinate are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Doxylamine Succinate landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Doxylamine Succinate include Teva, CHATTEM, DUCHESNAY, LNK INTERNATIONAL INC, PERRIGO, Viatris (MYLAN), Osmopharm, PAR PHARM INC and Renata Ltd. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Doxylamine Succinate capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Doxylamine Succinate by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Doxylamine Succinate Scope and Segment
Doxylamine Succinate market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Doxylamine Succinate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Solid
Liquor
Segment by Application
Antihistamine
Anticholinergic
Sedative
Others
By Company
Teva
CHATTEM
DUCHESNAY
LNK INTERNATIONAL INC
PERRIGO
Viatris (MYLAN)
Osmopharm
PAR PHARM INC
Renata Ltd
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Doxylamine Succinate Product Introduction
1.2 Market by Type
1.2.1 Global Doxylamine Succinate Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Solid
1.2.3 Liquor
1.3 Market by Application
1.3.1 Global Doxylamine Succinate Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Antihistamine
1.3.3 Anticholinergic
1.3.4 Sedative
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Doxylamine Succinate Production
2.1 Global Doxylamine Succinate Production Capacity (2017-2028)
2.2 Global Doxylamine Succinate Production by Region: 2017 VS 2021 VS 2028
2.3 Global Doxylamine Succinate Production by Region
2.3.1 Global Doxylamine Succinate Historic Production by Region (2017-2022)
2.3.2 Global Doxylamine Succinate Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Doxylamine Succinate Sales in Volume & Value Estimates and Forecasts
3.1 Global Doxylamine Succinate Sales Estimates and Forecasts 2017-2028
3.2 Global Doxylamine Succinate Revenue Estimates and Forecasts 2017-2028
3.3 Global Doxylamine Succinate Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Doxylamine Succinate Sales by Region
3.4.1 Global Doxylamine Succinate Sales by Region (2017-2022)
3.4.2 Global Sales Doxylamine Succinate by Region (2023-2028)
3.5 Global Doxylamine Succinate Revenue by Region
3.5.1 Global Doxylamine Succinate Revenue by Region (2017-2022)
3.5.2 Global Doxylamine Succinate Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Doxylamine Succinate Production Capacity by Manufacturers
4.2 Global Doxylamine Succinate Sales by Manufacturers
4.2.1 Global Doxylamine Succinate Sales by Manufacturers (2017-2022)
4.2.2 Global Doxylamine Succinate Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Doxylamine Succinate in 2021
4.3 Global Doxylamine Succinate Revenue by Manufacturers
4.3.1 Global Doxylamine Succinate Revenue by Manufacturers (2017-2022)
4.3.2 Global Doxylamine Succinate Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Doxylamine Succinate Revenue in 2021
4.4 Global Doxylamine Succinate Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Doxylamine Succinate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Doxylamine Succinate Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Doxylamine Succinate Sales by Type
5.1.1 Global Doxylamine Succinate Historical Sales by Type (2017-2022)
5.1.2 Global Doxylamine Succinate Forecasted Sales by Type (2023-2028)
5.1.3 Global Doxylamine Succinate Sales Market Share by Type (2017-2028)
5.2 Global Doxylamine Succinate Revenue by Type
5.2.1 Global Doxylamine Succinate Historical Revenue by Type (2017-2022)
5.2.2 Global Doxylamine Succinate Forecasted Revenue by Type (2023-2028)
5.2.3 Global Doxylamine Succinate Revenue Market Share by Type (2017-2028)
5.3 Global Doxylamine Succinate Price by Type
5.3.1 Global Doxylamine Succinate Price by Type (2017-2022)
5.3.2 Global Doxylamine Succinate Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Doxylamine Succinate Sales by Application
6.1.1 Global Doxylamine Succinate Historical Sales by Application (2017-2022)
6.1.2 Global Doxylamine Succinate Forecasted Sales by Application (2023-2028)
6.1.3 Global Doxylamine Succinate Sales Market Share by Application (2017-2028)
6.2 Global Doxylamine Succinate Revenue by Application
6.2.1 Global Doxylamine Succinate Historical Revenue by Application (2017-2022)
6.2.2 Global Doxylamine Succinate Forecasted Revenue by Application (2023-2028)
6.2.3 Global Doxylamine Succinate Revenue Market Share by Application (2017-2028)
6.3 Global Doxylamine Succinate Price by Application
6.3.1 Global Doxylamine Succinate Price by Application (2017-2022)
6.3.2 Global Doxylamine Succinate Price Forecast by Application (2023-2028)
7 North America
7.1 North America Doxylamine Succinate Market Size by Type
7.1.1 North America Doxylamine Succinate Sales by Type (2017-2028)
7.1.2 North America Doxylamine Succinate Revenue by Type (2017-2028)
7.2 North America Doxylamine Succinate Market Size by Application
7.2.1 North America Doxylamine Succinate Sales by Application (2017-2028)
7.2.2 North America Doxylamine Succinate Revenue by Application (2017-2028)
7.3 North America Doxylamine Succinate Sales by Country
7.3.1 North America Doxylamine Succinate Sales by Country (2017-2028)
7.3.2 North America Doxylamine Succinate Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Doxylamine Succinate Market Size by Type
8.1.1 Europe Doxylamine Succinate Sales by Type (2017-2028)
8.1.2 Europe Doxylamine Succinate Revenue by Type (2017-2028)
8.2 Europe Doxylamine Succinate Market Size by Application
8.2.1 Europe Doxylamine Succinate Sales by Application (2017-2028)
8.2.2 Europe Doxylamine Succinate Revenue by Application (2017-2028)
8.3 Europe Doxylamine Succinate Sales by Country
8.3.1 Europe Doxylamine Succinate Sales by Country (2017-2028)
8.3.2 Europe Doxylamine Succinate Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Doxylamine Succinate Market Size by Type
9.1.1 Asia Pacific Doxylamine Succinate Sales by Type (2017-2028)
9.1.2 Asia Pacific Doxylamine Succinate Revenue by Type (2017-2028)
9.2 Asia Pacific Doxylamine Succinate Market Size by Application
9.2.1 Asia Pacific Doxylamine Succinate Sales by Application (2017-2028)
9.2.2 Asia Pacific Doxylamine Succinate Revenue by Application (2017-2028)
9.3 Asia Pacific Doxylamine Succinate Sales by Region
9.3.1 Asia Pacific Doxylamine Succinate Sales by Region (2017-2028)
9.3.2 Asia Pacific Doxylamine Succinate Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Doxylamine Succinate Market Size by Type
10.1.1 Latin America Doxylamine Succinate Sales by Type (2017-2028)
10.1.2 Latin America Doxylamine Succinate Revenue by Type (2017-2028)
10.2 Latin America Doxylamine Succinate Market Size by Application
10.2.1 Latin America Doxylamine Succinate Sales by Application (2017-2028)
10.2.2 Latin America Doxylamine Succinate Revenue by Application (2017-2028)
10.3 Latin America Doxylamine Succinate Sales by Country
10.3.1 Latin America Doxylamine Succinate Sales by Country (2017-2028)
10.3.2 Latin America Doxylamine Succinate Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Doxylamine Succinate Market Size by Type
11.1.1 Middle East and Africa Doxylamine Succinate Sales by Type (2017-2028)
11.1.2 Middle East and Africa Doxylamine Succinate Revenue by Type (2017-2028)
11.2 Middle East and Africa Doxylamine Succinate Market Size by Application
11.2.1 Middle East and Africa Doxylamine Succinate Sales by Application (2017-2028)
11.2.2 Middle East and Africa Doxylamine Succinate Revenue by Application (2017-2028)
11.3 Middle East and Africa Doxylamine Succinate Sales by Country
11.3.1 Middle East and Africa Doxylamine Succinate Sales by Country (2017-2028)
11.3.2 Middle East and Africa Doxylamine Succinate Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Overview
12.1.3 Teva Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Teva Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Teva Recent Developments
12.2 CHATTEM
12.2.1 CHATTEM Corporation Information
12.2.2 CHATTEM Overview
12.2.3 CHATTEM Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 CHATTEM Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 CHATTEM Recent Developments
12.3 DUCHESNAY
12.3.1 DUCHESNAY Corporation Information
12.3.2 DUCHESNAY Overview
12.3.3 DUCHESNAY Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 DUCHESNAY Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 DUCHESNAY Recent Developments
12.4 LNK INTERNATIONAL INC
12.4.1 LNK INTERNATIONAL INC Corporation Information
12.4.2 LNK INTERNATIONAL INC Overview
12.4.3 LNK INTERNATIONAL INC Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 LNK INTERNATIONAL INC Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 LNK INTERNATIONAL INC Recent Developments
12.5 PERRIGO
12.5.1 PERRIGO Corporation Information
12.5.2 PERRIGO Overview
12.5.3 PERRIGO Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 PERRIGO Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 PERRIGO Recent Developments
12.6 Viatris (MYLAN)
12.6.1 Viatris (MYLAN) Corporation Information
12.6.2 Viatris (MYLAN) Overview
12.6.3 Viatris (MYLAN) Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Viatris (MYLAN) Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Viatris (MYLAN) Recent Developments
12.7 Osmopharm
12.7.1 Osmopharm Corporation Information
12.7.2 Osmopharm Overview
12.7.3 Osmopharm Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Osmopharm Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Osmopharm Recent Developments
12.8 PAR PHARM INC
12.8.1 PAR PHARM INC Corporation Information
12.8.2 PAR PHARM INC Overview
12.8.3 PAR PHARM INC Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 PAR PHARM INC Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 PAR PHARM INC Recent Developments
12.9 Renata Ltd
12.9.1 Renata Ltd Corporation Information
12.9.2 Renata Ltd Overview
12.9.3 Renata Ltd Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Renata Ltd Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Renata Ltd Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Doxylamine Succinate Industry Chain Analysis
13.2 Doxylamine Succinate Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Doxylamine Succinate Production Mode & Process
13.4 Doxylamine Succinate Sales and Marketing
13.4.1 Doxylamine Succinate Sales Channels
13.4.2 Doxylamine Succinate Distributors
13.5 Doxylamine Succinate Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Doxylamine Succinate Industry Trends
14.2 Doxylamine Succinate Market Drivers
14.3 Doxylamine Succinate Market Challenges
14.4 Doxylamine Succinate Market Restraints
15 Key Finding in The Global Doxylamine Succinate Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer